ChipCare Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
ChipCare General Information
Description
Developer of a microfluidic diagnostic platform designed to bring lifesaving diagnostics to inaccessible populations. The company's platform offers a point-of-care system that uses disposable microfluidic cartridges to run nucleic acid tests, multiplexed immunoassays, and cell analysis on a drop of blood, thereby enabling healthcare providers to perform diagnostic tests and save the lives of patients by starting therapy earlier.
Contact Information
Website
www.chipcare.caCorporate Office
- 555 Richmond Street West
- Post Office Box Number 705
- Toronto, Ontario M5V 3B1
- Canada
Corporate Office
- 555 Richmond Street West
- Post Office Box Number 705
- Toronto, Ontario M5V 3B1
- Canada
ChipCare Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Later Stage VC (Series B) | 17-Nov-2016 | Completed | Generating Revenue | |||
| 5. Grant | 01-Apr-2015 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 03-Mar-2015 | Completed | Generating Revenue | |||
| 3. Seed Round | 16-Sep-2013 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2012 | $1.2M | Completed | Generating Revenue | ||
| 1. University Spin-Out | 01-Jan-2009 | Completed | Startup |
ChipCare Comparisons
Industry
Financing
Details
ChipCare Competitors (13)
One of ChipCare’s 13 competitors is Cepheid, a Formerly VC-backed company based in Sunnyvale, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cepheid | Formerly VC-backed | Sunnyvale, CA | ||||
| BioFire | Venture Capital-Backed | Salt Lake City, UT | ||||
| Biocartis | Venture Capital-Backed | Mechelen, Belgium | ||||
| Genalyte | Venture Capital-Backed | San Diego, CA | ||||
| Abaxis | Formerly VC-backed | Union City, CA |
ChipCare Patents
ChipCare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2015352119-A1 | Multiplex bead array assay | Inactive | 28-Nov-2014 | ||
| AU-2021203651-A1 | Multiplex bead array assay | Inactive | 28-Nov-2014 | ||
| CA-2969078-A1 | Multiplex bead array assay | Inactive | 28-Nov-2014 | ||
| EP-3224594-A1 | Multiplex bead array assay | Inactive | 28-Nov-2014 | ||
| EP-3224594-A4 | Multiplex bead array assay | Inactive | 28-Nov-2014 | G01N15/147 |
ChipCare Signals
ChipCare Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| University of Toronto | University | |||
| University of Toronto Entrepreneurship | Accelerator/Incubator |
ChipCare FAQs
-
When was ChipCare founded?
ChipCare was founded in 2009.
-
Where is ChipCare headquartered?
ChipCare is headquartered in Toronto, Canada.
-
What is the size of ChipCare?
ChipCare has 10 total employees.
-
What industry is ChipCare in?
ChipCare’s primary industry is Diagnostic Equipment.
-
Is ChipCare a private or public company?
ChipCare is a Private company.
-
What is ChipCare’s current revenue?
The current revenue for ChipCare is .
-
How much funding has ChipCare raised over time?
ChipCare has raised $10M.
-
Who are ChipCare’s investors?
University of Toronto and University of Toronto Entrepreneurship have invested in ChipCare.
-
Who are ChipCare’s competitors?
Cepheid, BioFire, Biocartis, Genalyte, and Abaxis are some of the 13 competitors of ChipCare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process